EXPERTISE & PASSION
Genoskin is a team innovative minds with a heart for challenges
Genoskin is powered by a team of young innovative minds. Our passion makes us push the boundaries of skin research every day. Genoskin’s collaborators strive to stay reliable and trustworthy skin experts. Keeping innovation at heart, we will do anything to meet our common goals.
MAKE SCIENCE MOVE FORWARD
A WORD ABOUT OUR FOUNDER AND CEO
After obtaining his PhD in Human Pathophysiology at the University of Toulouse in 2006, Pascal completed a 2 year post-doctorate fellowship at the University of San Diego in California. His interest for skin research was demonstrated by his thesis, i.e. “A rare skin disease called Netherton Syndrome”. He also holds Master’s Degree in Management from the Toulouse Business School and has over 14 years of experience in skin biology research.
In 2005, he received LeoPharma’s Charles Grupper Award for his work and in 2007, he won the Award for Medicine from the Toulouse Academy of Science. His research has been published in major magazines, such as Nature Genetics, PNAS and the Journal of Investigative Dermatology.
In 2009, Pascal started working on his project to develop more adequate human skin models with the French National Center for Research and the Paul Sabatier University, which led to the creation of Genoskin in 2011. By combining his constructive managerial skills with his sense for philanthropy, Pascal strives to turn Genoskin into the best toolbox for researchers who want to move forward using better and more ethical testing techniques.
MEET OUR CCO
Eric has held commercial roles in life science companies globally for over 15 years. Eric has spent his career developing commercial strategies for some of the life science industry’s most recognizable companies. He was most recently at Intrexon (XON), where he led the development of the Consumer Sector portfolio and business strategy as the senior director of strategic alliances and innovation. Prior to Intrexon, Eric Merle developed growth strategies for the Life Sciences division of SGS (SGSN), the world’s leading inspection, verification, testing, and certification company. He has also held commercial roles at Cellectis (CLLS), Sigma Aldrich (SIAL), Becton Dickinson (BDX), and Fisher Scientific (TMO).
MEET OUR COO
Claire holds a Biochemistry and Molecular Biology degree from the National Institute of Applied Science (INSA, Toulouse). She also studied at the Technical University of Vienna, Austria, and speaks English, German, and French fluently. Claire joined Genoskin in 2013 as part of her Ph.D. thesis. Her research focused on the development of an ex vivo human skin cancer model.
Following her Ph.D., Claire took leadership of our Production department in France and set up a task management program for the technical team. She is now in charge of both the Production and Service departments for the group. Claire manages the operational side of our activity, including resources optimization, team coordination and engagement, results control, strategy implementation, and change management. With over eight years of experience at Genoskin and strong expertise in skin, Claire ensures the best quality of our solutions across both locations.
MEET OUR CFO
Frederick is French-American with 20 years of experience in international finance, most recently as executive director at EY. Frederick has worked on projects around the world and specializes in global digital transformation. With his multi-sector and multi-standard (IFRS, US GAAP, PCG) experience, he will continue to structure, transform and optimize the financial aspects of Genoskin. Frederick holds a Masters in Finance, Accounting and Business Administration from the University of Toulouse.
MEET OUR CSO
Dr Gaudenzio completed his PhD in 2012 at the University of Toulouse, France, and holds a doctorate in immunology. Following his post-doctorate in the Department of Pathology at Stanford University (CA, USA), he now heads an Inserm cross-disciplinary research group, which was awarded a Starting Grant from the European Research Council (ERC) in 2018. His work has contributed substantially to identifying molecular and cellular targets involved in allergic and non-allergic inflammation and to the development of new imaging methods to probe neuro-immune interactions in preclinical models and in skin samples from patients. His current research work in these fields will contribute to the further comprehension of the role of structural, neuronal and immune cells in the development of skin inflammation and pain, which should help identify new therapeutic options to modulate and prevent disease development. In 2021, Dr Gaudenzio received the prestigious ACTERIA Early Career Research Prize in Allergology awarded every two years by the European Federation of Immunological Societies (EFIS).
Dr Gaudenzio’s work has been published in prestigious scientific journals such as Nature Immunology, Nature Medicine, Nature Communication and the Journal of Allergy and Clinical Immunology. He is a member of the European Academy of Allergy and Clinical Immunology (EAACI) and the French Society for Immunology (SFI).